PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Nepafenac - Postoperative pain and inflammation (eye)

PAD Profile : Nepafenac - Postoperative pain and inflammation (eye)

Brand Names Include :
Nevanac

Traffic Light Status

Status 1 of 1.

Status :
Red
Formulations :
  • Eye drops
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
Comments :
No comments returned.
Documents :

Guidelines

No guidelines returned.

Other Drugs

Other Indications

No indications returned.

Additional Documents

No additional documents returned.

Committee Recommendations

Date
Committee Name
Narrative
28 November 2013
ASPH DTC

The committee supported the use of nepafenac within its licensed indications. As treatment is short term postoperatively (up to 60 days with a review by the specialist 1 month post operatively) it was agreed that this would be considered as a red drug on the traffic light system.

Associated BNF Codes

11. Eye
11.08.02. Ocular diagnostic & peri-operative prepn & photodynamic tt
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
Learn More